Established in 1958, China Medical University (CMU) in Taichung, Taiwan, has since developed into one of the world’s premiere medical research universities with 8 colleges total: the College of Medicine, the College of Chinese Medicine, the College of Pharmacy, the College of Biopharmaceutical and Food Sciences, the College of Public Health, the College of Health Care, the College of Dentistry, and the College of Humanities and Technology. Its Joint Commission International (JCI)-accredited hospitals have a total of over 5,000 beds, and it offers the second largest healthcare system nationwide.
As a leader in several research fields with a culture of collaboration and innovation, CMU has made important breakthroughs in cancer treatment such as lengthening the survival of glioblastoma patients, discovering ANK-199, a promising anticancer drug that treats head and neck cancer, and identifying the receptor protein IL17RB that is strongly associated with pancreatic cancer. For cultivating talent and advancing the boundaries of knowledge, outstanding international experts have been recruited from around the world to join the 500 full-time, dedicated CMU faculty members who are all passionate about making the world a better place.
Devoted to improving health through sciences, CMU’s high ranking in many surveys and lists reflects its effort and determination for excellence: it was placed in the top 151~200 of universities in the 2016 Academic Ranking of World Universities (ARWU); it was in the top 150 in the field of Clinical Medicine and Pharmacy in the 2016 Academic Ranking of World Universities (ARWU); it was 46th in the Times Higher Education Asia University Rankings; it was in the top 401~500 universities in the World University Rankings; and it was in the top 101~150 in Pharmacy and Pharmacology in the 2017 QS World University Rankings by Subject.
International collaborative partnerships with prestigious institutions such as Stanford University and the M.D. Anderson Cancer Center have been firmly established. Additionally, over 80 international healthcare companies and venture capitalists are assisting the university with its knowledge transfer mission. Thus far, over 60 new drugs have emerged from CMU’s research laboratories, as well as 9 new spin-off companies.
As a provider of medical services to the community, an educator of future health care professionals, and a contributor to the world’s knowledge in health sciences, CMU will continue to strive for excellence in clinical care, education, and research.